EOLS (STOCKS)
Evolus, Inc. Common Stock
$6.730000
+0.000000 (+0.00%)
Prev close: $6.730000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- David Moatazedi
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $444.19M
- Employees
- 329
- P/E (TTM)
- -10.07
- P/B (TTM)
- -15.44
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $301.79M |
| Benefits Costs and Expenses | $344.35M |
| Cost Of Revenue | $102.44M |
| Costs And Expenses | $223.69M |
| Gross Profit | $199.35M |
| Operating Expenses | $223.69M |
| Selling, General, and Administrative Expenses | $216.13M |
| Depreciation and Amortization | $5.06M |
| Other Operating Expenses | $2.50M |
| Operating Income/Loss | -$24.34M |
| Income/Loss From Continuing Operations After Tax | -$43.42M |
| Income/Loss From Continuing Operations Before Tax | -$42.56M |
| Income Tax Expense/Benefit | $861.00K |
| Income Tax Expense/Benefit, Deferred | $21.00K |
| Net Income/Loss | -$43.42M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$43.42M |
| Net Income/Loss Available To Common Stockholders, Basic | -$43.42M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.67 |
| Diluted Earnings Per Share | -$0.67 |
| Basic Average Shares | 194,596,596 |
| Diluted Average Shares | 194,596,596 |
| Assets | $220.65M |
| Current Assets | $138.92M |
| Inventory | $24.80M |
| Prepaid Expenses | $4.62M |
| Other Current Assets | $109.51M |
| Noncurrent Assets | $81.72M |
| Fixed Assets | $5.34M |
| Intangible Assets | $46.74M |
| Other Non-current Assets | $29.65M |
| Liabilities | $249.43M |
| Current Liabilities | $68.02M |
| Accounts Payable | $19.53M |
| Wages | $9.40M |
| Other Current Liabilities | $39.10M |
| Noncurrent Liabilities | $181.40M |
| Long-term Debt | $156.41M |
| Other Non-current Liabilities | $24.99M |
| Equity | -$28.78M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$28.78M |
| Liabilities And Equity | $220.65M |
| Net Cash Flow From Operating Activities | -$36.59M |
| Net Cash Flow From Operating Activities, Continuing | -$36.59M |
| Net Cash Flow From Investing Activities | -$8.28M |
| Net Cash Flow From Investing Activities, Continuing | -$8.28M |
| Net Cash Flow From Financing Activities | $26.59M |
| Net Cash Flow From Financing Activities, Continuing | $26.59M |
| Exchange Gains/Losses | $178.00K |
| Net Cash Flow | -$18.10M |
| Net Cash Flow, Continuing | -$18.28M |
| Comprehensive Income/Loss | -$43.10M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$42.86M |
| Other Comprehensive Income/Loss | -$25.96M |
| Other Comprehensive Income/Loss Attributable To Parent | $561.00K |